Heptares Therapeutics is clinical stage company using innovative techniques in protein engineering and structure based drug design directed at G protein-coupled receptors (GPCRs). Heptares has built an exciting pipeline of new medicines across disease areas including Alzheimer's disease, migraine and cancer. Our ability to address highly validated, yet historically undruggable, GPCRs has also attracted multiple partners including Allergan, AstraZeneca, Daiichi Sankyo, Kymab, Morphosys, Pfizer an…
via http://ift.tt/1puljGFArticles to help early drug hunters on understanding drug likeness and lead optimization techniques. Girinath
Friday, 16 June 2017
Head of Computational Chemistry
Heptares Therapeutics Ltd is clinical stage company using innovative techniques in protein engineering and structure-based drug design directed at G protein-coupled receptors (GPCRs). Heptares has built an exciting pipeline of new medicines across disease areas including Alzheimer's disease, migraine and cancer. Our ability to address highly validated, yet historically undruggable, GPCRs has also attracted multiple partners including Allergan, AstraZeneca, Daiichi Sankyo, Kymab, Morphosys, Pfize…
via http://ift.tt/1puljGF
Subscribe to:
Posts (Atom)